potentially a multiple of the current price, page-3

Yep, successful phase 3 result should see ALC trade at $1+. FDA approval should see $2+. Successful partnership and/or another success in a HyAct phase 3 trial (probably 2-3 years away) would see more like $4 to $5 per share.

There is a reason we are patient holders or accumulators. Depending on your risk profile and capital to invest, there are hundreds of thousands or millions of dollars to be made here. But it is not without risk. You shouldn't be investing a cent that you can't kiss goodbye. Improbable in my opinion, but definitely possible.